267 related articles for article (PubMed ID: 32279656)
1. Single-Center Experience of Recurrence Patterns and Survival Analyses of Patients With Hepatocellular Carcinoma and Liver Transplant.
Rahatli S; Ayvazoglu Soy EH; Oguz A; Altundag O; Moray G; Haberal M
Exp Clin Transplant; 2020 Apr; 18(2):201-205. PubMed ID: 32279656
[TBL] [Abstract][Full Text] [Related]
2. Expanded Criteria for Hepatocellular Carcinoma in Liver Transplant.
Haberal M; Akdur A; Moray G; Arslan G; Özçay F; Selçuk H; Özdemir H
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):55-58. PubMed ID: 28302000
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Patients With Hepatocellular Carcinoma After Liver Transplant.
Moray G; Kirnap M; Akdur A; Soy E; Tezcaner T; Boyvat F; Ozdemir H; Haberal M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():30-2. PubMed ID: 26640906
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Resection and Liver Transplant in Treatment of Hepatocellular Carcinoma.
Aksoy SO; Unek T; Sevinc Aİ; Arslan B; Sirin H; Derici ZS; Ellidokuz H; Sagol O; Agalar C; Astarcıoglu İ
Exp Clin Transplant; 2020 Nov; 18(6):712-718. PubMed ID: 29957158
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
6. Outcome of Living-Donor Liver Transplant for Hepatocellular Carcinoma: 15-Year Single-Center Experience in Egypt.
Kamel R; Hatata Y; Hosny K; Nabil A; El-Deen Abd-Allah A; Mostafa A; Abdel-Aal A; Elganzoury MZ; Elmalt O; Marwan I; Hosny A
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):12-20. PubMed ID: 28301993
[TBL] [Abstract][Full Text] [Related]
7. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
8. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.
de Ataide EC; Garcia M; Mattosinho TJ; Almeida JR; Escanhoela CA; Boin IF
Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of Milan, University of California San Francisco, and Up-To-7 Criteria in Predicting Tumor Recurrence Following Deceased-Donor Liver Transplant in Patients With Hepatocellular Carcinoma.
Saberi B; Garonzik-Wang J; Ma M; Ajayi T; Kim A; Luu H; Jakhete N; Pustavoitau A; Anders RA; Georgiades C; Kamel I; Ottmann S; Philosophe B; Cameron AM; Gurakar A
Exp Clin Transplant; 2020 Aug; 18(4):463-469. PubMed ID: 30084757
[TBL] [Abstract][Full Text] [Related]
10. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients.
Akbulut S; Kayaalp C; Yilmaz M; Ince V; Ozgor D; Karabulut K; Eris C; Toprak HI; Aydin C; Yilmaz S
World J Gastroenterol; 2013 Mar; 19(10):1625-31. PubMed ID: 23538988
[TBL] [Abstract][Full Text] [Related]
11. Effect of Downstaging and Bridging of Hepatocellular Carcinoma on Survival Following Liver Transplant: A Single Center Experience.
Al Sebayel MI; Elsiesy H; Al-Hamoudi W; Alabbad S; ElSheikh Y; Elbeshbeshy H; Salih I; Yousif S; Saleh Y; Eldali A; Abaalkhail FA
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):7-11. PubMed ID: 28301992
[TBL] [Abstract][Full Text] [Related]
12. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.
Mazzaferro V; Llovet JM; Miceli R; Bhoori S; Schiavo M; Mariani L; Camerini T; Roayaie S; Schwartz ME; Grazi GL; Adam R; Neuhaus P; Salizzoni M; Bruix J; Forner A; De Carlis L; Cillo U; Burroughs AK; Troisi R; Rossi M; Gerunda GE; Lerut J; Belghiti J; Boin I; Gugenheim J; Rochling F; Van Hoek B; Majno P;
Lancet Oncol; 2009 Jan; 10(1):35-43. PubMed ID: 19058754
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria).
Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC
Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
[TBL] [Abstract][Full Text] [Related]
15. Effects of risk factors and Ki-67 on rates of recurrence on patients who have undergone liver transplant for hepatocellular carcinoma.
Aktas S; Karakayali H; Moray G; Ozdemir H; Haberal M
Transplant Proc; 2011 Dec; 43(10):3807-12. PubMed ID: 22172851
[TBL] [Abstract][Full Text] [Related]
16. Liver Transplant for Hepatocellular Carcinoma in Post-Milan Criteria Era: A Long-Term Single-Center Experience.
Kasraianfard A; Moradi AM; Nassiri-Toosi M; Jafarian A
Exp Clin Transplant; 2024 Jan; 22(Suppl 1):252-255. PubMed ID: 38385407
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.
Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
Xu X; Lu D; Ling Q; Wei X; Wu J; Zhou L; Yan S; Wu L; Geng L; Ke Q; Gao F; Tu Z; Wang W; Zhang M; Shen Y; Xie H; Jiang W; Wang H; Zheng S
Gut; 2016 Jun; 65(6):1035-41. PubMed ID: 25804634
[TBL] [Abstract][Full Text] [Related]
19. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
Na GH; Kim EY; Hong TH; You YK; Kim DG
HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
[TBL] [Abstract][Full Text] [Related]
20. Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria.
Alim A; Erdogan Y; Dayangac M; Yuzer Y; Tokat Y; Oezcelik A
Cancer Control; 2021; 28():10732748211011960. PubMed ID: 33926242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]